Effective and safe treatment of anti-CD38 therapy in systemic lupus erythematosus-associated refractory cerebral vasculitis induces immune tolerance

Effective and safe treatment of anti-CD38 therapy in systemic lupus erythematosus-associated refractory cerebral vasculitis induces immune tolerance

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Rheumatology (Oxford, England) England), 2023-02, Vol.62 (2), p.e21-e23
Hauptverfasser: Yalcin Mutlu, Melek, Wacker, Jochen, Tascilar, Koray, Taubmann, Jule, Manger, Bernhard, Krönke, Gerhard, Schett, Georg, Simon, David
Format: Artikel
Sprache:eng
Schlagworte:
Humans
Immune Tolerance
Lupus Erythematosus, Systemic - complications
Lupus Erythematosus, Systemic - drug therapy
Vasculitis, Central Nervous System - drug therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e23
container_issue 2
container_start_page e21
container_title Rheumatology (Oxford, England)
container_volume 62
creator Yalcin Mutlu, Melek
Wacker, Jochen
Tascilar, Koray
Taubmann, Jule
Manger, Bernhard
Krönke, Gerhard
Schett, Georg
Simon, David
description
doi_str_mv 10.1093/rheumatology/keac393
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2687716422</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2687716422</sourcerecordid><originalsourceid>FETCH-LOGICAL-c307t-f62e1a27cd0cbc46ef889a8904b26e200404e4021db54a018cf1c3e13e73b4403</originalsourceid><addsrcrecordid>eNpNUctO3TAQtRCoPNo_QJWXbALjx81jWd3SgoTEhq4jxxmDaRLfemyk_Ec_uEbcIlYzmjmPGR3GzgVcCujUVXzCPJsUpvC4Xv1GY1WnDtiJ0LWsQCl5-N5LfcxOiZ4BYCNU-4kdq00LopNwwv5eO4c2-RfkZhk5GYc8RTRpxiXx4Mo0-Wr7XbU8PWE0u5X7hdNKCWdv-ZR3mTjGtSxfj6FMlSEK1puEI4_oorEpxJVbjDhEM_EXQzZPPnkqSmO2WOo856X4hqk4LBY_syNnJsIv-3rGfv24ftjeVHf3P2-33-4qq6BJlaslCiMbO4IdrK7RtW1n2g70IGuUABo0apBiHDbagGitE1ahUNioQWtQZ-ziTXcXw5-MlPrZk8VpMguGTL2s26YRtZayQPUb1MZAVP7qd9HPJq69gP41j_5jHv0-j0L7unfIw4zjO-l_AOofC7ePww</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2687716422</pqid></control><display><type>article</type><title>Effective and safe treatment of anti-CD38 therapy in systemic lupus erythematosus-associated refractory cerebral vasculitis induces immune tolerance</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Yalcin Mutlu, Melek ; Wacker, Jochen ; Tascilar, Koray ; Taubmann, Jule ; Manger, Bernhard ; Krönke, Gerhard ; Schett, Georg ; Simon, David</creator><creatorcontrib>Yalcin Mutlu, Melek ; Wacker, Jochen ; Tascilar, Koray ; Taubmann, Jule ; Manger, Bernhard ; Krönke, Gerhard ; Schett, Georg ; Simon, David</creatorcontrib><identifier>ISSN: 1462-0324</identifier><identifier>EISSN: 1462-0332</identifier><identifier>DOI: 10.1093/rheumatology/keac393</identifier><identifier>PMID: 35801920</identifier><language>eng</language><publisher>England</publisher><subject>Humans ; Immune Tolerance ; Lupus Erythematosus, Systemic - complications ; Lupus Erythematosus, Systemic - drug therapy ; Vasculitis, Central Nervous System - drug therapy</subject><ispartof>Rheumatology (Oxford, England), 2023-02, Vol.62 (2), p.e21-e23</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c307t-f62e1a27cd0cbc46ef889a8904b26e200404e4021db54a018cf1c3e13e73b4403</citedby><cites>FETCH-LOGICAL-c307t-f62e1a27cd0cbc46ef889a8904b26e200404e4021db54a018cf1c3e13e73b4403</cites><orcidid>0000-0001-8310-7820 ; 0000-0003-2375-0069</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35801920$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yalcin Mutlu, Melek</creatorcontrib><creatorcontrib>Wacker, Jochen</creatorcontrib><creatorcontrib>Tascilar, Koray</creatorcontrib><creatorcontrib>Taubmann, Jule</creatorcontrib><creatorcontrib>Manger, Bernhard</creatorcontrib><creatorcontrib>Krönke, Gerhard</creatorcontrib><creatorcontrib>Schett, Georg</creatorcontrib><creatorcontrib>Simon, David</creatorcontrib><title>Effective and safe treatment of anti-CD38 therapy in systemic lupus erythematosus-associated refractory cerebral vasculitis induces immune tolerance</title><title>Rheumatology (Oxford, England)</title><addtitle>Rheumatology (Oxford)</addtitle><subject>Humans</subject><subject>Immune Tolerance</subject><subject>Lupus Erythematosus, Systemic - complications</subject><subject>Lupus Erythematosus, Systemic - drug therapy</subject><subject>Vasculitis, Central Nervous System - drug therapy</subject><issn>1462-0324</issn><issn>1462-0332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNUctO3TAQtRCoPNo_QJWXbALjx81jWd3SgoTEhq4jxxmDaRLfemyk_Ec_uEbcIlYzmjmPGR3GzgVcCujUVXzCPJsUpvC4Xv1GY1WnDtiJ0LWsQCl5-N5LfcxOiZ4BYCNU-4kdq00LopNwwv5eO4c2-RfkZhk5GYc8RTRpxiXx4Mo0-Wr7XbU8PWE0u5X7hdNKCWdv-ZR3mTjGtSxfj6FMlSEK1puEI4_oorEpxJVbjDhEM_EXQzZPPnkqSmO2WOo856X4hqk4LBY_syNnJsIv-3rGfv24ftjeVHf3P2-33-4qq6BJlaslCiMbO4IdrK7RtW1n2g70IGuUABo0apBiHDbagGitE1ahUNioQWtQZ-ziTXcXw5-MlPrZk8VpMguGTL2s26YRtZayQPUb1MZAVP7qd9HPJq69gP41j_5jHv0-j0L7unfIw4zjO-l_AOofC7ePww</recordid><startdate>20230201</startdate><enddate>20230201</enddate><creator>Yalcin Mutlu, Melek</creator><creator>Wacker, Jochen</creator><creator>Tascilar, Koray</creator><creator>Taubmann, Jule</creator><creator>Manger, Bernhard</creator><creator>Krönke, Gerhard</creator><creator>Schett, Georg</creator><creator>Simon, David</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8310-7820</orcidid><orcidid>https://orcid.org/0000-0003-2375-0069</orcidid></search><sort><creationdate>20230201</creationdate><title>Effective and safe treatment of anti-CD38 therapy in systemic lupus erythematosus-associated refractory cerebral vasculitis induces immune tolerance</title><author>Yalcin Mutlu, Melek ; Wacker, Jochen ; Tascilar, Koray ; Taubmann, Jule ; Manger, Bernhard ; Krönke, Gerhard ; Schett, Georg ; Simon, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c307t-f62e1a27cd0cbc46ef889a8904b26e200404e4021db54a018cf1c3e13e73b4403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Humans</topic><topic>Immune Tolerance</topic><topic>Lupus Erythematosus, Systemic - complications</topic><topic>Lupus Erythematosus, Systemic - drug therapy</topic><topic>Vasculitis, Central Nervous System - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yalcin Mutlu, Melek</creatorcontrib><creatorcontrib>Wacker, Jochen</creatorcontrib><creatorcontrib>Tascilar, Koray</creatorcontrib><creatorcontrib>Taubmann, Jule</creatorcontrib><creatorcontrib>Manger, Bernhard</creatorcontrib><creatorcontrib>Krönke, Gerhard</creatorcontrib><creatorcontrib>Schett, Georg</creatorcontrib><creatorcontrib>Simon, David</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Rheumatology (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yalcin Mutlu, Melek</au><au>Wacker, Jochen</au><au>Tascilar, Koray</au><au>Taubmann, Jule</au><au>Manger, Bernhard</au><au>Krönke, Gerhard</au><au>Schett, Georg</au><au>Simon, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effective and safe treatment of anti-CD38 therapy in systemic lupus erythematosus-associated refractory cerebral vasculitis induces immune tolerance</atitle><jtitle>Rheumatology (Oxford, England)</jtitle><addtitle>Rheumatology (Oxford)</addtitle><date>2023-02-01</date><risdate>2023</risdate><volume>62</volume><issue>2</issue><spage>e21</spage><epage>e23</epage><pages>e21-e23</pages><issn>1462-0324</issn><eissn>1462-0332</eissn><cop>England</cop><pmid>35801920</pmid><doi>10.1093/rheumatology/keac393</doi><orcidid>https://orcid.org/0000-0001-8310-7820</orcidid><orcidid>https://orcid.org/0000-0003-2375-0069</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1462-0324
ispartof Rheumatology (Oxford, England), 2023-02, Vol.62 (2), p.e21-e23
issn 1462-0324
1462-0332
language eng
recordid cdi_proquest_miscellaneous_2687716422
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects Humans
Immune Tolerance
Lupus Erythematosus, Systemic - complications
Lupus Erythematosus, Systemic - drug therapy
Vasculitis, Central Nervous System - drug therapy
title Effective and safe treatment of anti-CD38 therapy in systemic lupus erythematosus-associated refractory cerebral vasculitis induces immune tolerance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T15%3A00%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effective%20and%20safe%20treatment%20of%20anti-CD38%20therapy%20in%20systemic%20lupus%20erythematosus-associated%20refractory%20cerebral%20vasculitis%20induces%20immune%20tolerance&rft.jtitle=Rheumatology%20(Oxford,%20England)&rft.au=Yalcin%20Mutlu,%20Melek&rft.date=2023-02-01&rft.volume=62&rft.issue=2&rft.spage=e21&rft.epage=e23&rft.pages=e21-e23&rft.issn=1462-0324&rft.eissn=1462-0332&rft_id=info:doi/10.1093/rheumatology/keac393&rft_dat=%3Cproquest_cross%3E2687716422%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2687716422&rft_id=info:pmid/35801920&rfr_iscdi=true